Skip to main content

Advertisement

Log in

Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

We study the clinical, management and outcome differences between respiratory syncytial virus (RSV) positive and negative bronchiolitis. A retrospective review of the medical records of children ≤ 2 years of age with acute bronchiolitis between January 1995 and December 2006 was done. There were 2,384 patients hospitalized for acute bronchiolitis, and 1,495 (62.7%) were RSV infections. Overall, hospitalization rate was 55/1,000 admissions. Mortality occurred in 0.08% of cases. Bronchiolitis due to RSV was more frequent from November to March (97%). RSV bronchiolitis had longer hospital stays (6 vs. 5 days, P<0.0001), higher risk of intensive care unit (ICU) admission (OR 2.7; 95%CI 1.87–3.9) and more oxygen use (OR 2.2; 95%CI 1.8–2.6). Infants < 2 months had longer median hospital stay (6 vs. 5 days, P <0.0001) and higher risk of ICU admission (OR 3.4; 95%CI 2.5–4.6). Prematures of < 32 gestational weeks, congenital heart disease, and atelectasis/condensation were the main risk factors for ICU admission in both RSV and non-RSV bronchiolitis. The introduction of palivizumab in prematures diminished hospitalization for RSV bronchiolitis, oxygen need, length of hospital stay and mechanical ventilation. In conclusion, this study supports that RSV bronchiolitis seems to be a more severe disease than that caused by other viruses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ (1999) Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282:1440–1446

    Article  PubMed  CAS  Google Scholar 

  2. Mansbach JM, Emond JA, Camargo CA (2005) Bronchiolitis in US emergency departments 1992 to 2000. Epidemiology and practice variation. Pediatr Emerg Care 21:242–247

    Article  PubMed  Google Scholar 

  3. Manoha C, Espinosa S, Aho SL, Huet F, Pothier P (2007) Epidemiological and clinical features of hMPV, RSV and RVs infections in young children. J Clin Virol 38:221–226

    Article  PubMed  Google Scholar 

  4. Richard N, Komurian-Pradel F, Javouhey E, Perret M, Rajoharison A, Bagnaud A, Billaud G, Vernet G, Lina B, Floret D, Paranhos-Baccalà G (2008) The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J 27:213–217

    Article  PubMed  Google Scholar 

  5. Simoes E, Carbonell-Extrany X (2003) Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 22:S13–S22

    PubMed  Google Scholar 

  6. Tsolia MN, Kafetzis D, Danelatou K, Astral H, Kallergi K, Spyridis P, Karpathios TE (2002) Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. Eur J Epidemiol 18:55–61

    Article  Google Scholar 

  7. Purcell K, Driscoll FJ (2004) Children's hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 23:418–423

    Article  PubMed  Google Scholar 

  8. Calvo C, García-García ML, Blanco C, Vázquez MC, Frías ME, Pérez-Breña P, Casas I (2008) Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain. J Clin Virol 42:268–272

    Article  PubMed  Google Scholar 

  9. Stensballe LG, Devasundaram JK, Simoes EAF (2003) Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J 22:S21–S32

    PubMed  Google Scholar 

  10. Alonso A, Andres JM, Garmendia JR, Diez I, Gil JM, Ardura J (2007) Bronchiolitis due to respiratory syncytial virus in hospitalized children: a study of seasonal rhythm. Acta Paediatr 96:731–735

    Article  PubMed  CAS  Google Scholar 

  11. Dagan R, Landau D, Haikin H, Tal A (1993) Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus. Pediatr Infect Dis J 12:381–386

    Article  PubMed  CAS  Google Scholar 

  12. Piastra M, Polidori G, De Carolis MP, Tempera A, Caresta E, Pulitanò S, Chiaretti A, Valentini P, De Rosa G (2005) Fatal coronary artery anomaly presenting as bronchiolitis. Eur J Pediatr 164:515–519

    Article  PubMed  Google Scholar 

  13. Langley GF, Anderson LJ (2011) Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 30:510–517

    PubMed  Google Scholar 

  14. Chan PW, Lok FY, Khatijah SB (2002) Risk factors for hypoxemia and respiratory failure in respiratory syncytial virus bronchiolitis. Southeast Asian J Trop Med Public Health 33:806–810

    PubMed  CAS  Google Scholar 

  15. Boyce TG, Mellen BG, Mitchel EF, Wright PF, Griffin MR (2000) Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 137:865–870

    Article  PubMed  CAS  Google Scholar 

  16. Lind I, Gill JH, Calabretta N (2006) What are hospital admission criteria for infants with bronchiolitis? J Fam Practice 55:67–69

    Google Scholar 

  17. Heikkinen T, Valkonen H, Lehtonen L, Vainionpää R, Ruuskanen O (2005) Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis. Arch Dis Child Fetal Neonatal Ed 90:F64–F68

    Article  PubMed  CAS  Google Scholar 

  18. Pedraz C, Carbonell-Estrany X, Figueras-Aloy J, Quero J, and the IRIS Study Group (2003) Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants. Pediatr Infect Dis J 22:823–827

    Article  PubMed  Google Scholar 

  19. The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–537

    Article  Google Scholar 

  20. Garcia CG, Bhore R, Soriano-Fallas A, Trost M, Chason R, Ramilo O, Mejías A (2010) Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 126(6):e1453–1460

    Article  PubMed  Google Scholar 

  21. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis (2006) Diagnosis and management of bronchiolitis. Pediatrics 118:1774–1793

    Article  Google Scholar 

  22. Harris JA, Huskins WC, Langley JM, Siegel JD, Pediatric Special Interest Group of the Society for Healthcare Epidemiology of America (2007) Health care epidemiology perspective on the October 2006 recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis. Pediatrics 120:890–892

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. A. Hervás.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hervás, D., Reina, J., Yañez, A. et al. Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. Eur J Clin Microbiol Infect Dis 31, 1975–1981 (2012). https://doi.org/10.1007/s10096-011-1529-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1529-y

Keywords

Navigation